Drugs / 5FU 225mg/m2 continuous infusion on days 1-42 during radiation
5FU 225mg/m2 continuous infusion on days 1-42 during radiation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00006472 | Jan 2000 → Nov 2001 | esophageal cancer | Medstar Health Research Institute | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5FU 225mg/m2 continuous infusion on days 1-42 during radiation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006472 ↗ |
| Route | Intravenous | “fluorouracil IV continuously” NCT00006472 ↗ |